BIOXYTRAN, INC (BIXT) › Shareholders' EquityBIOXYTRAN, INC (BIXT) — Shareholders' EquityAnnual figures by period end, from SEC filings.2008-06-08: $02008-12-31: -$20.1K2009-12-31: -$100.5K2010-12-31: -$56.0K2011-12-31: $163.3K2017-12-31: -$1.3K2018-12-31: -$225.3K2019-12-31: -$799.3K2020-12-31: -$1.94M2021-12-31: -$3.16M2022-12-31: -$3.30M2023-12-31: -$3.10M2024-12-31: -$1.79M2025-12-31: -$2.59M-$2.59M2008-06-08Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31-$2.59M—2026-04-15Balance as of period end2024-12-31-$1.79M—2026-04-15Balance as of period end2023-12-31-$3.10M—2026-04-15Balance as of period end2022-12-31-$3.30M—2025-04-03Balance as of period end2021-12-31-$3.16M—2025-01-13Balance as of period end2020-12-31-$1.94M—2023-03-31Balance as of period end2019-12-31-$799.3K—2020-03-18Balance as of period end2018-12-31-$225.3K—2020-03-18Balance as of period end2017-12-31-$1.3K—2020-03-18Balance as of period end2011-12-31$163.3K—2012-12-31Balance as of period end2010-12-31-$56.0K—2012-12-31Balance as of period end2009-12-31-$100.5K—2012-12-31Balance as of period end2008-12-31-$20.1K—2012-12-31Balance as of period end2008-06-08$0—2012-03-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)